Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH Côte d'Ivoire: Azithromycin MDA for Child Mortality
NCT04617626Completed
- Sponsor
- FHI 360
- Start
- Nov 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azithromycin in child mortality (U5MR) and trachoma, sponsored by FHI 360. Primary endpoint: Proportion of children 1 to 11 months reached with single-dose azithromycin. Started Nov 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
child mortality (U5MR)trachoma
Beyond the preview
Go deeper on NCT04617626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04617626.